Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 15 February 2024
      European business calls for deepening the EU Single Market and renewing the dynamic of European integration
 
 
Read the joint statement from 26 trade associations.
 

After two centuries at the vanguard of technological development and innovation, in the past two decades Europe has dramatically lost its edge. The US and China are growing faster, putting them in a pole position to create more prosperity and a greener and more advanced digital future, while the EU’s competitiveness continues to fade.

With geopolitics shifting, policymakers in the European Commission and EU Member States have increasingly focused on mapping strategic dependencies, anticipating vulnerabilities, beefing up autonomy, and de-risking.

 

Read more →
 
 
      International Childhood Cancer Day

15 February marks International Childhood Cancer Day, providing an opportunity to raise awareness and emphasise the importance of supporting research to give all children with cancer the best chance to live their dreams. Thanks to medical advances, today, 80% of children survive 5 years or more after diagnosis, but we know that more can be done. With cancer remaining the leading cause of death by disease among children in Europe, we are committed to continuing our efforts to  to discover, develop and deliver innovative treatments to create a future where no families are affected by cancer.

 
 
      EU Immunisation Strategy: From Progress to Excellence

"The upcoming elections in June offer a unique opportunity to reinforce and strengthen public health prevention efforts. The time to act is now. The EU’s recent initiatives on strengthened cooperation against vaccine-preventable diseases provide a groundwork upon which Europe and its Member States can build stronger immunisation policies. Prioritising and fortifying these policies can pave the way for transparent collaboration among stakeholders, equitable access across Member States, and ultimately, a healthier, more prosperous Europe."

Read the new blog post from Sibilia Quilici, Executive Director, Vaccines Europe.

 
 
      Events
 
 
19 FEB 2024
  EUCROF24 Prague

7th European conference on clinical research

Learn more →
 
 
 
20 FEB 2024
  Getting to the heart of the matter: improving cardiovascular health in Europe Virtual event

Join us to be at the forefront of shaping cardiovascular health management in the EU.

Learn more →
 
 
 
29 FEB 2024
  International Congress on Rare Diseases and Orphan Drugs Athens and online

Navigating the Uncharted: Advancements, Collaborations, and Hope in Rare Diseases

Learn more →
 
 
 
07 MAR 2024
  Digitally-enabled healthcare: Is our ecosystem on track? Brussels and online

Organised by the EU Health Coalition.

Learn more →
 
 
      What we are reding
‘A Maze Of Rules’: EFPIA On EU’s Proposed Health Data Sharing Law 12 February 2024  (Pink Sheet) Read more →
Childhood diabetes crisis stalks Europe, more screening urged 09 February 2024  (Euractiv) Read more →
IHI celebrates the International Day of Women and Girls in Science 07 February 2024  (IHI) Read more →
Unlocking the potential of therapeutic adherence as a priority for a forward-looking approach... 01 February 2024  (therapeuticadherence-policies.com) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe